XML 47 R20.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Note 10 - Stock Compensation | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Share-Based Payment Arrangement [Text Block] | Note 10. Stock Compensation 2021 Omnibus Incentive Plan The 2021 Omnibus Incentive Plan (the Plan) authorizes the grant of stock options, stock appreciation rights (SARs), RSUs and performance share units (PSUs) through April 2031. Cash-settled awards do not count against the number of shares available for award under the Plan. At December 31, 2024, there were 4.3 million shares available for future grants. Shares of common stock to be issued under the Plan are made available from authorized and unissued Dana common stock. Award activity — (shares in millions)
|  | RSUs |  |  |  |  |  |  | PSUs |
|  |  |  |  |  | Grant-Date |  |  |  |  |  |  | Grant-Date |
|  | Shares |  |  | Fair Value* |  |  | Shares |  |  | Fair Value* |
December 31, 2023 |  |  | 1.9 |  |  | $ | 20.05 |  |  |  | 0.7 |  |  | $ | 21.70 |
Granted |  |  | 2.9 |  |  |  | 11.25 |  |  |  | 0.7 |  |  |  | 13.23 |
Vested |  |  | (1.0 | ) |  |  | 20.08 |  |  |  | (0.5 | ) |  |  | 18.83 |
Expired |  |  | (0.6 | ) |  |  | 14.95 |  |  |  | (0.1 | ) |  |  | 12.20 |
December 31, 2024 |  |  | 3.2 |  |  |  | 12.76 |  |  |  | 0.8 |  |  |  | 13.59 |
* Weighted-average per share
|  | 2024 |  |  | 2023 |  |  | 2022 |
Total stock compensation expense |  | $ | 30 |  |  | $ | 26 |  |  | $ | 19 |
Total grant-date fair value of awards vested |  |  | 31 |  |  |  | 33 |  |  |  | 19 |
Cash received from exercise of stock options |  |  |  |  |  |  | 3 |  |  |  |  |
Cash paid to settle SARs and RSUs |  |  | 4 |  |  |  | 5 |  |  |  | 4 |
Intrinsic value of stock options and SARs exercised |  |  |  |  |  |  | 1 |  |  |  |  |
Intrinsic value of RSUs and PSUs vested |  |  | 21 |  |  |  | 30 |  |  |  | 21 |
Compensation expense is generally measured based on the fair value at the date of grant and is recognized on a straight-line basis over the vesting period. For RSUs and PSUs, the fair value is based on the closing market price of our common stock at the date of grant. Awards that are settled in cash are subject to liability accounting. Accordingly, the fair value of such awards is remeasured at the end of each reporting period until settled or expired. We had accrued $2 for cash-settled awards at both December 31, 2024 and 2023. During 2024 we issued 0.8 million and 0.2 million shares of common stock based on vesting of RSUs and PSUs, respectively. At December 31, 2024, the total unrecognized compensation cost related to the nonvested awards granted and expected to vest was $28. This cost is expected to be recognized over a weighted-average period of 1.4 years. Stock options and stock appreciation rights — The exercise price of each option or SAR equals the closing market price of our common stock on the date of grant. SARs are settled in cash for the difference between the market price on the date of exercise and the exercise price. We have not granted stock options or SARs since 2013. At December 31, 2024, there were no outstanding stock options or SARs as they have all been exercised or expired. Restricted stock units and performance shares units — Each RSU or PSU granted represents the right to receive one share of Dana common stock or, at the election of Dana (for units awarded to board members) or for employees located outside the U.S. (for employee awarded units), cash equal to the market value per share. All RSUs contain dividend equivalent rights. RSUs granted to non-employee directors vest on the first anniversary date of the grant and those granted to employees pro-rata vest over three years. PSUs granted to employees vest if specified performance goals are achieved during the respective performance period, generally three years. Under the 2024, 2023, and 2022 stock compensation award programs, the number of PSUs that ultimately vest is contingent on achieving specified financial targets and specified total shareholder return targets relative to peer companies. For the portions of the awards based on financial metrics, we estimated the fair value at grant date based on the closing market price of our common stock at the date of grant adjusted for the value of assumed dividends over the period because the awards are not dividend protected. The estimated grant date value is accrued over the performance period and adjusted as appropriate based on performance relative to the target. For the portion of the PSU award based on shareholder returns, we estimated the fair value at grant date using various assumptions as part of a Monte Carlo simulation. The expected term represents the period from the grant date to the end of the performance period. The risk-free interest rate was based on U.S. Treasury constant maturity rates at the grant date. The dividend yield was calculated using our historical approach calculated by dividing the expected annual dividend by the average stock price over the prior year. The estimated volatility was based on observed historical volatility of daily stock returns for the 3-year period preceding the grant date.
|  | PSUs |
|  | 2024 |  |  | 2023 |
Expect term (in years) |  |  | 3.0 |  |  |  | 3.0 |
Risk-free interest rate |  |  | 4.39 | % |  |  | 4.28 | %
Dividend yield |  |  | 2.7 | % |  |  | 2.5 | %
Expected volatility |  |  | 47.7 | % |  |  | 67.0 | %
Cash incentive awards — Our 2021 Omnibus Incentive Plan provides for cash incentive awards. We make awards annually to certain eligible employees designated by Dana, including certain executive officers. Awards under the plan are primarily based on achieving certain financial performance goals. The financial performance goals of the plan are established annually by the Board of Directors. Under the 2024 annual incentive program, participants were eligible to receive cash awards based on achieving earnings, net new business and cash flow performance goals. Under the 2023 and 2022 annual incentive programs, participants were eligible to receive cash awards based on achieving earnings, sales and cash flow performance goals. We accrued $57, $98 and $37 of expense in 2024, 2023 and 2022 for the expected cash payments under these programs.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration